Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Nine Months Ended September 30, 2017	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	8,030,102		$	414,784		$	—		$	7,615,318
Less: Provision for uncollectible accounts	(352,228		)	(11,010		)	—			(341,218		)
Net patient service operating revenues	7,677,874			403,774			—			7,274,100
Capitated revenues	2,956,479			1,186,185			—			1,770,294
Other revenues	863,238			33,688			—			829,550
Total net operating revenues	11,497,591			1,623,647			—			9,873,944
Operating expenses	10,423,562			1,572,064			(147		)	8,851,645
Operating income	1,074,029			51,583			147			1,022,299
Debt expense, including refinancing charges	(322,014		)	(6,458		)	—			(315,556		)
Other income	13,866			478			—			13,388
Income tax expense	276,005			38,059			59			237,887
Net income	489,876			7,544			88			482,244
Less: Net income attributable to noncontrolling interests	(129,654		)	—			—			(129,654		)
Net income attributable to DaVita Inc.	$	360,222		$	7,544		$	88		$	352,590


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Nine Months Ended September 30, 2017	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	489,876		$	7,544	$	88	$	482,244
Other comprehensive income	93,117			—		—		93,117
Total comprehensive income	582,993			7,544		88		575,361
Less: Comprehensive income attributable to the noncontrolling interests	(129,652		)	—		—		(129,652		)
Comprehensive income attributable to DaVita Inc.	$	453,341		$	7,544	$	88	$	445,709


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of September 30, 2017	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	846,110	$	162,536	$	—	$	683,574
Accounts receivable, net	2,091,074		174,944		—		1,916,130
Other current assets	1,096,365		17,722		—		1,078,643
Total current assets	4,033,549		355,202		—		3,678,347
Property and equipment, net	3,386,056		3,334		—		3,382,722
Amortizable intangibles, net	1,451,033		4,313		—		1,446,720
Other long-term assets	726,824		81,877		2,861		642,086
Goodwill	9,415,877		30,993		—		9,384,884
Total assets	$	19,013,339	$	475,719	$	2,861	$	18,534,759
Current liabilities	$	2,874,793	$	202,386	$	—	$	2,672,407
Payables to parent	—		97,434		2,861		(100,295		)
Long-term debt and other long-term liabilities	10,142,527		63,272		—		10,079,255
Noncontrolling interests subject to put provisions	1,026,890		—		—		1,026,890
Total DaVita Inc. shareholders’ equity	4,784,581		112,627		—		4,671,954
Noncontrolling interests not subject to put provisions	184,548		—		—		184,548
Shareholders’ equity	4,969,129		112,627		—		4,856,502
Total liabilities and shareholder’s equity	$	19,013,339	$	475,719	$	2,861	$	18,534,759


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Nine Months Ended September 30, 2017	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	489,876		$	7,544		$	88		$	482,244
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	1,074,663			29,753			(88		)	1,044,998
Net cash provided by operating activities	1,564,539			37,297			—			1,527,242
Cash flows from investing activities:
Additions of property and equipment	(639,829		)	(5,903		)	—			(633,926		)
Acquisitions	(726,538		)	—			—			(726,538		)
Proceeds from asset and business sales	92,529			—			—			92,529
Investments and other items	166,605			(2,378		)	—			168,983
Net cash used in investing activities	(1,107,233		)	(8,281		)	—			(1,098,952		)
Cash flows from financing activities:
Long-term debt	(108,463		)	—			—			(108,463		)
Intercompany	—			28,829			—			(28,829		)
Other items	(421,369		)	—			—			(421,369		)
Net cash (used in) provided by financing activities	(529,832		)	28,829			—			(558,661		)
Effect of exchange rate changes on cash	5,449			—			—			5,449
Net (decrease) increase in cash	(67,077		)	57,845			—			(124,922		)
Cash and cash equivalents at beginning of period	913,187			104,691			—			808,496
Cash and cash equivalents at end of period	$	846,110		$	162,536		$	—		$	683,574


(1)	After elimination of the unrestricted subsidiaries and the physician groups.